These three biotechs have kicked off the new year in a very bullish way, but where do things go from here for Novavax, Q Biomed and Axsome Therapeutics?
2019 is off to a buliish start for the biotech sector and three companies' bullish news and charts are worth examining as investors wonder what the markets may hold next.
"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'. Add this page to your favorite Social Bookmarking websites